{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:26:50Z","timestamp":1787016410588,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1124\/jpet.121.000675","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T14:35:10Z","timestamp":1621607710000},"page":"146-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A Comparison of Breathing Stimulants for Reversal of Synthetic Opioid-Induced Respiratory Depression in Conscious Rats"],"prefix":"10.1016","volume":"378","author":[{"given":"Kaye E","family":"Dandrea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F","family":"Cotten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.121.000675_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-2999(75)90197-1","article-title":"Etonitazine-induced rigidity and its antagonism by centrally acting muscle relaxants","volume":"30","author":"Barnett","year":"1975","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.121.000675_bib2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00000542-199711000-00010","article-title":"Difficult or impossible ventilation after sufentanil-induced anesthesia is caused primarily by vocal cord closure","volume":"87","author":"Bennett","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.121.000675_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1476-5381.1960.tb00277.x","article-title":"The anatomical basis of the straub phenomenon","volume":"15","author":"Bilbey","year":"1960","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1124\/jpet.121.000675_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/jpet.118.248377","article-title":"Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats","volume":"366","author":"Boghosian","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"issue":"Pt A","key":"10.1124\/jpet.121.000675_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.brainres.2015.11.026","article-title":"5-hydroxytryptamine1A (5-HT1A) receptor agonists: A decade of empirical evidence supports their use as an efficacious therapeutic strategy for brain trauma","volume":"1640","author":"Cheng","year":"2016","journal-title":"Brain Res"},{"key":"10.1124\/jpet.121.000675_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1213\/ANE.0b013e318284469d","article-title":"TASK-1 (KCNK3) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane-anesthetized rats","volume":"116","author":"Cotten","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.121.000675_bib7","series-title":"PKTHPP Enhances the Ventilatory Response to Carbon Dioxide and Reverses Opioid Induced Respiratory Depression","author":"Cotten","year":"2016"},{"key":"10.1124\/jpet.121.000675_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression","volume":"112","author":"Dahan","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.121.000675_bib9","unstructured":"Doucette C (2017) Carfentanil: The drug of mass destruction in Toronto Sun."},{"key":"10.1124\/jpet.121.000675_bib10","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1098\/rstb.2009.0076","article-title":"The potency of different serotonergic agonists in counteracting opioid evoked cardiorespiratory disturbances","volume":"364","author":"Dutschmann","year":"2009","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1124\/jpet.121.000675_bib11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1213\/ane.0b013e318198f828","article-title":"The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo","volume":"108","author":"Guenther","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.121.000675_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/ALN.0b013e31823d08fa","article-title":"Selective 5-HT(1A)-R-agonist repinotan prevents remifentanil-induced ventilatory depression and prolongs antinociception","volume":"116","author":"Guenther","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.121.000675_bib13","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1213\/ANE.0b013e3181eac011","article-title":"Repinotan, a selective 5-HT1A-R-agonist, antagonizes morphine-induced ventilatory depression in anesthetized rats","volume":"111","author":"Guenther","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.121.000675_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1399-6576.1982.tb01765.x","article-title":"Potent, new analgesics, tailor-made for different purposes","volume":"26","author":"Janssen","year":"1982","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1124\/jpet.121.000675_bib15","first-page":"19","article-title":"Attenuation of the fentanyl-induced muscle rigidity by the selective 5HT1A agonist 8-OH-DPAT","volume":"47","author":"Jaros","year":"1995","journal-title":"Pol J Pharmacol"},{"key":"10.1124\/jpet.121.000675_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0091-3057(87)90226-7","article-title":"Reversal of opioid-induced muscular rigidity in rats: evidence for alpha-2 adrenergic involvement","volume":"28","author":"Jerussi","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.121.000675_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/jpet.111.187237","article-title":"Is hydrogen sulfide-induced suspended animation general anesthesia?","volume":"341","author":"Li","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000675_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0304-3940(90)90728-R","article-title":"Involvement of coerulospinal noradrenergic pathway in fentanyl-induced muscular rigidity in rats","volume":"108","author":"Lui","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.121.000675_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.1084674","article-title":"5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia","volume":"301","author":"Manzke","year":"2003","journal-title":"Science"},{"key":"10.1124\/jpet.121.000675_bib20","doi-asserted-by":"crossref","first-page":"R405","DOI":"10.1152\/ajpregu.00440.2005","article-title":"Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats","volume":"290","author":"Meyer","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.121.000675_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.clpt.6100018","article-title":"The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans","volume":"81","author":"Oertel","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.121.000675_bib22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1089\/08977150152725614","article-title":"Repinotan (BAY x 3702): a 5HT1A agonist in traumatically brain injured patients","volume":"18","author":"Ohman","year":"2001","journal-title":"J Neurotrauma"},{"key":"10.1124\/jpet.121.000675_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1113\/jphysiol.2014.285171","article-title":"RNASeq-derived transcriptome comparisons reveal neuromodulatory deficiency in the CO2 insensitive brown Norway rat","volume":"593","author":"Puissant","year":"2015","journal-title":"J Physiol"},{"key":"10.1124\/jpet.121.000675_bib24","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/ALN.0b013e31819faa2a","article-title":"Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats","volume":"110","author":"Ren","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.121.000675_bib25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/ALN.0000000000000490","article-title":"5-HT1A receptor agonist Befiradol reduces fentanyl-induced respiratory depression, analgesia, and sedation in rats","volume":"122","author":"Ren","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.121.000675_bib26","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/ALN.0000000000002676","article-title":"Activating \u03b14\u03b22 Nicotinic Acetylcholine Receptors Alleviates Fentanyl-induced Respiratory Depression in Rats","volume":"130","author":"Ren","year":"2019","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.121.000675_bib27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0022-3565(24)35342-X","article-title":"Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors","volume":"292","author":"Sahibzada","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000675_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0952-8180(94)90087-6","article-title":"Pretreatment with sedative-hypnotics, but not with nondepolarizing muscle relaxants, attenuates alfentanil-induced muscle rigidity","volume":"6","author":"Sanford","year":"1994","journal-title":"J Clin Anesth"},{"key":"10.1124\/jpet.121.000675_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/420007a","article-title":"Hostage deaths put gas weapons in spotlight","volume":"420","author":"Schiermeier","year":"2002","journal-title":"Nature"},{"key":"10.1124\/jpet.121.000675_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12630-019-01295-x","article-title":"Carfentanil: a weapon of mass destruction","volume":"66","author":"Shafer","year":"2019","journal-title":"Can J Anaesth"},{"key":"10.1124\/jpet.121.000675_bib31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00000542-199304000-00003","article-title":"Fentanyl-induced rigidity and unconsciousness in human volunteers. Incidence, duration, and plasma concentrations","volume":"78","author":"Streisand","year":"1993","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.121.000675_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/acem.13034","article-title":"Fatal Fentanyl: One Pill Can Kill","volume":"24","author":"Sutter","year":"2017","journal-title":"Acad Emerg Med"},{"key":"10.1124\/jpet.121.000675_bib33","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1161\/STROKEAHA.109.551382","volume":"40","author":"Teal","year":"2009","journal-title":"Stroke"},{"key":"10.1124\/jpet.121.000675_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.119.258566","article-title":"Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis","volume":"371","author":"Torralva","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000675_bib35","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/0028-3908(89)90206-2","article-title":"Differential effects of prazosin and yohimbine on fentanyl-induced muscular rigidity in rats","volume":"28","author":"Tsou","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.121.000675_bib36","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1002\/phar.2117","article-title":"The Pharmacokinetics and Pharmacodynamics of Carfentanil After Recreational Exposure: A Case Report","volume":"38","author":"Uddayasankar","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1124\/jpet.121.000675_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic Advances from the Brain Disease Model of Addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.121.000675_bib38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yrtph.2010.12.007","article-title":"Uniform assessment and ranking of opioid \u03bc receptor binding constants for selected opioid drugs","volume":"59","author":"Volpe","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1124\/jpet.121.000675_bib39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000542-198908000-00013","article-title":"Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat","volume":"71","author":"Weinger","year":"1989","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.121.000675_bib40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1124\/jpet.121.000675_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13181-019-00750-x","article-title":"National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6\/7, 2019","volume":"16","author":"Yeung","year":"2020","journal-title":"J Med Toxicol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.121.000675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:52:54Z","timestamp":1739955174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524257001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0022356524257001"],"URL":"https:\/\/doi.org\/10.1124\/jpet.121.000675","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comparison of Breathing Stimulants for Reversal of Synthetic Opioid-Induced Respiratory Depression in Conscious Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.121.000675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}